MPD: Measures involving ovariectomy

Measures involving ovariectomy

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Tarantino2:1	Tarantino2	open field test	ovariectomy	distance traveled, 10 min test [cm] OFT_distance 50601 control ovariectomy	inbred	37	f	10-12wks	N=9	2016

Tarantino2:6	Tarantino2	open field test	ovariectomy	time spent mobile, 10 min test [s] OFT_movement 50606 control ovariectomy	inbred	37	f	10-12wks	N=9	2016

Tarantino2:11	Tarantino2	open field test	ovariectomy	number of vertical movements, 10 min teste [n] OFT_vertical 50611 control ovariectomy	inbred	37	f	10-12wks	N=9	2016

Tarantino2:16	Tarantino2	open field test	ovariectomy	distance traveled in center of arena, 10 min test [cm] OFT_center_distance 50616 control ovariectomy	inbred	37	f	10-12wks	N=9	2016

Tarantino2:21	Tarantino2	open field test	ovariectomy	duration in center of arena, 10 min test [s] OFT_center_duration 50621 control ovariectomy	inbred	37	f	10-12wks	N=9	2016

Tarantino2:26	Tarantino2	open field test	ovariectomy	percentage of time spent in center of arena, 10 min test [%] OFT_center_duration_pct 50626 control ovariectomy	inbred	37	f	10-12wks	N=9	2016

Tarantino2:31	Tarantino2	open field test	ovariectomy	distance traveled in periphery of arena, 10 min test [cm] OFT_thigmotaxis 50631 control ovariectomy	inbred	37	f	10-12wks	N=9	2016

Tarantino2:36	Tarantino2	forced swim test	ovariectomy	percentage of time spent immobile, 6 min test [%] FST_immobility 50636 control ovariectomy	inbred	36	f	10-12wks	N=8	2016

Other available data sets:

Data set	Procedure	What's in this data set	Panel	Sex	Age (weeks)	Year
ITP1	uterus weight with (R/S)-1,3-butanediol, 17-a-estradiol, 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride, 2-(2-Hydroxyphenyl)benzoxazole, 3-(3-hydroxybenzyl)-5-methylbenzo[d]oxazol-2(3H)-one, 4-OH-a-phenyl-N-tert-butyl nitrone, 4-phenylbutyrate, acarbose, aspirin, astaxanthin, b-guanidinopropionic acid, caffeic acid phenethyl ester, canagliflozin, captopril, candesartan cilexetil, curcumin, dimethyl fumarate, enalapril, fisetin, fish oil, geranylgeranyl acetone, glycine, green tea extract, INT-767 FXR/TGR5 agonist, inulin, L-Leucine, meclizine, medium-chain triglyceride, metformin, metformin plus rapamycin, methylene blue, minocycline, MitoQ, mycophenolic acid, nicotinamide riboside, nitroflurbiprofen, nordihydroguaiaretic acid, oxaloacetic acid, PB125, protandim, rapamycin, rapamycin plus acarbose, resveratrol, SG1002, simvastatin, sulindac, syringaresinol, TM5441, ursodeoxycholic acid, ursolic acid, 16-a-hydroxyestriol, 2,4-dinitrophenol, a-Ketoglutarate, Hydralazine, Nebivolol, Sodium thiosulfate	Uterus weight, ovariectomy study with and without an intervention.	UM-HET3 population	both	various	2004-2024